Lyophilized Sterile Vial
Tested: 99.6% (GHK) / 99.4% (BPC) / 99.2% (TB)
Current Lot: MV-2026-KLW70-02
Multi-Peptide Precision Synergy
KLOW Precision Blend (GHK-Cu + BPC-157 + TB-500)
70mg / 5mL Lyophilized Multi-Compound • HPLC Purity: 99.6% (GHK) / 99.4% (BPC) / 99.2% (TB) • Target: ≥ 99.0% per component
Tri-peptide regeneration matrix combining high-concentration copper peptide with BPC-157 and TB-500 to evaluate comprehensive extracellular matrix synthesis, angiogenesis, and cell motility.
Wholesale Commercial Pricing
Verified Provider Portal Required
• No consumer checkout • Tiered volume schedules • Certificate included with shipment
Formula Multi-Component Tri-Active Matrix
Molecular Weight Co-Lyophilized Tri-Peptide
CAS Registry # 49557-75-7 / 137525-51-0 / 77591-33-4
Peptide Sequence / Structure GHK-Cu (50mg) + BPC-157 (10mg) + TB-500 (10mg)
Current Lot Verification
Historical Lot Archive → Lot #MV-2026-KLW70-02 Analytical Results
Independent laboratory testing panel for active distribution batch.
| Analysis Category | Reported Result | Analytical Method | Verification Status |
|---|---|---|---|
| GHK-Cu Content & Purity | 50.2 mg (99.6%) | RP-HPLC & ICP-OES | Conforms |
| BPC-157 Content & Purity | 10.1 mg (99.4%) | RP-HPLC | Conforms |
| TB-500 Content & Purity | 10.0 mg (99.2%) | RP-HPLC | Conforms |
| Endotoxin Level | < 0.05 EU/mg | LAL Kinetic | Conforms |
Biological Mechanism of Action
GHK-Cu stimulates dermal fibroblast collagen/decorin synthesis, BPC-157 enhances microvascular network formation, and TB-500 accelerates actin-mediated cellular migration.
Research Focus Areas: Tri-Active Matrix Extracellular Remodeling Tissue Repair
Scientific Literature Cross-Reference
Explore primary peer-reviewed papers, PubMed indexes, and pharmacology data for KLOW Blend.